Therapix Biosciences Announces Positive Data From Recent Pre-clinical Study for New Drug Candidate THX-210
TEL AVIV, Israel, Oct. 15, 2019 /PRNewswire/ -- Therapix Biosciences Ltd. (NASDAQ: TRPX), a specialty, clinical-stage pharmaceutical company focusing on...